Anixa Revenue Per Share from 2010 to 2024

ANIX Stock  USD 3.30  0.01  0.30%   
Anixa Biosciences Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 0.01 in 2024. Revenue Per Share is the amount of revenue generated by Anixa Biosciences per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
0.006101
Current Value
0.005796
Quarterly Volatility
20.9545218
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
  
Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Anixa Biosciences over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Anixa Biosciences' Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 010 Years Trend
Pretty Stable
   Revenue Per Share   
       Timeline  

Anixa Revenue Per Share Regression Statistics

Arithmetic Mean5.55
Geometric Mean0.07
Coefficient Of Variation377.84
Mean Deviation10.10
Median0.03
Standard Deviation20.95
Sample Variance439.09
Range81.2808
R-Value0.24
Mean Square Error445.00
R-Squared0.06
Significance0.38
Slope1.14
Total Sum of Squares6,147

Anixa Revenue Per Share History

2024 0.005796
2023 0.006101
2022 0.006779
2021 81.29
2019 0.0179
2018 0.0126
2017 0.0631

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 0.01  0.01 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.